Review: In adults with type 1 diabetes, SGLT-2 inhibitors reduce HbA1c but increase diabetic ketoacidosis

被引：4
|
作者：
Egan, Aoife M. [1 ]
Montori, Victor M. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2018年 / 169卷 / 02期
关键词：
D O I：
10.7326/ACPJC-2018-169-2-003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC3 / JC3
页数：1
相关论文
共 50 条
  • [1] SGLT-2 inhibitors and diabetic ketoacidosis
    Agozzino, Francesco
    De Falco, Teresa
    Villa, Antonio
    INTERNAL AND EMERGENCY MEDICINE, 2025, : 337 - 340
  • [2] Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels
    Fredheim, S.
    Johannesen, J.
    Johansen, A.
    Lyngsoe, L.
    Rida, H.
    Andersen, M. L. M.
    Lauridsen, M. H.
    Hertz, B.
    Birkebaek, N. H.
    Olsen, B.
    Mortensen, H. B.
    Svensson, J.
    DIABETOLOGIA, 2013, 56 (05) : 995 - 1003
  • [3] The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes
    Govan, L.
    Maietti, E.
    Torsney, B.
    Wu, O.
    Briggs, A.
    Colhoun, H. M.
    Fischbacher, C. M.
    Leese, G. P.
    McKnight, J. A.
    Morris, A. D.
    Sattar, N.
    Wild, S. H.
    Lindsay, R. S.
    DIABETOLOGIA, 2012, 55 (09) : 2356 - 2360
  • [4] Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels
    S. Fredheim
    J. Johannesen
    A. Johansen
    L. Lyngsøe
    H. Rida
    M. L. M. Andersen
    M. H. Lauridsen
    B. Hertz
    N. H. Birkebæk
    B. Olsen
    H. B. Mortensen
    J. Svensson
    Diabetologia, 2013, 56 : 995 - 1003
  • [5] The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes
    L. Govan
    E. Maietti
    B. Torsney
    O. Wu
    A. Briggs
    H. M. Colhoun
    C. M. Fischbacher
    G. P. Leese
    J. A. McKnight
    A. D. Morris
    N. Sattar
    S. H. Wild
    R. S. Lindsay
    Diabetologia, 2012, 55 : 2356 - 2360
  • [6] SGLT-2 inhibitors: risk of diabetic ketoacidosis
    Reactions Weekly, 2020, 1815 (1) : 10 - 10
  • [7] RE: DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES ON SGLT-2 INHIBITORS: AN ONGOING CONCERN
    Bell, David S. H.
    ENDOCRINE PRACTICE, 2018, 24 (01) : 126 - 126
  • [8] SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes
    Griffin, Tomas P.
    Dinneen, Sean F.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : JC40 - JC40
  • [9] SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios
    Doumas, Michael
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 261 - 272
  • [10] Concurrent diabetes medications does not influence the change in HbA1c or weight observed with SGLT-2 inhibitors in patients with Type 2 diabetes under routine care
    Markakis, K.
    Shaikh, A.
    Jinadev, P.
    Thabit, H.
    Rutter, M. K.
    Boulton, A. J.
    Leelarantha, L.
    DIABETIC MEDICINE, 2018, 35 : 200 - 200
12345